Efficacy and safety of neostigmine on treating gastrointestinal dysmotility in severe acute pancreatitis patients: study protocol for a randomized controlled trial

This study is registered on chictr.org.cn with the identifier as ChiCTR2200058305. Registered on April 5, 2022.
Source: Trials - Category: Research Source Type: clinical trials